CLOs on the Move

Precision Inc

www.precision-inc.com

 
Precision Inc. is a growing leader in the design and manufacture of transformers and inductors for the electronics industry. Since 1964, we have been providing solutions from heat pumps to pacemakers. To maintain our leadership position, we have a
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Westborough Behavioral Healthcare Hospital

Westborough Behavioral Healthcare Hospital is a mental health care hospital that provides consistent levels of excellent service and an attitude of caring expressed by the entire organization.

Camp Xcel

The Top Fitness Boot Camp Known To Flatten Your Stomach & Tone Your Entire Body In A Safe, Fun And Non-Intimidating Atmosphere!  90% OFF 5 Week Challenge

Manatee Community Blood Ctr

Manatee Community Blood Ctr is a Bradenton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Adamas Pharmaceuticals, Inc.

Adamas Pharmaceuticals, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Emeryville, CA. To find more information about Adamas Pharmaceuticals, Inc., please visit www.adamaspharma.com

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.